{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:44:52Z","timestamp":1774280692965,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1006\/excr.2001.5449","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T19:02:41Z","timestamp":1033930961000},"page":"157-167","source":"Crossref","is-referenced-by-count":10,"title":["Activation of NF-\u03baB Is Required for PDGF-B Chain to Transform NIH3T3 Cells"],"prefix":"10.1006","volume":"274","author":[{"given":"Takeshi","family":"Shimamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tin-Chen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy H.","family":"Colburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce E.","family":"Bejcek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/excr.2001.5449_RF1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ijc.2910360218","article-title":"Production of PDGF-like growth factor by breast cancer cell lines","volume":"36","author":"Rozengurt","year":"1985","journal-title":"Int. J. Cancer"},{"key":"10.1006\/excr.2001.5449_RF2","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1073\/pnas.84.16.5763","article-title":"Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines","volume":"84","author":"Bronzert","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2001.5449_RF3","doi-asserted-by":"crossref","first-page":"16755","DOI":"10.1016\/S0021-9258(18)55365-5","article-title":"Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines","volume":"266","author":"Nister","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5449_RF4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jcp.1041650204","article-title":"Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect","volume":"165","author":"Hsu","year":"1995","journal-title":"J. Cell. Phys."},{"key":"10.1006\/excr.2001.5449_RF5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1096-9896(199801)184:1<44::AID-PATH984>3.0.CO;2-H","article-title":"Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops","volume":"184","author":"De Jong","year":"1998","journal-title":"J. Pathol."},{"key":"10.1006\/excr.2001.5449_RF6","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1128\/MCB.13.12.7203","article-title":"Dominant negative mutant of the platelet derived growth factor reverts the transformed phenotype of human astrocytoma cells","volume":"13","author":"Shamah","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2001.5449_RF7","doi-asserted-by":"crossref","first-page":"21215","DOI":"10.1016\/S0021-9258(17)31950-6","article-title":"Inhibition of glioma cell growth by a truncated platelet-derived growth factor-b receptor","volume":"269","author":"Strawn","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5449_RF8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jcp.1041580221","article-title":"Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line","volume":"158","author":"Vassbotn","year":"1994","journal-title":"J. Cell. Phys."},{"key":"10.1006\/excr.2001.5449_RF9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/j.1460-2075.1988.tb02955.x","article-title":"Binding of different dimeric forms of PDGF to human fibroblasts: Evidence for two separate receptor types","volume":"7","author":"Heldin","year":"1989","journal-title":"EMBO J."},{"key":"10.1006\/excr.2001.5449_RF10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/35010579","article-title":"PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor","volume":"2","author":"Li","year":"2000","journal-title":"Nature Cell Biol."},{"key":"10.1006\/excr.2001.5449_RF11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/35074593","article-title":"PDGF-D, a new protease-activated growth factor","volume":"3","author":"LaRochelle","year":"2001","journal-title":"Nature Cell Biol."},{"key":"10.1006\/excr.2001.5449_RF12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/35074588","article-title":"PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor","volume":"3","author":"Bergsten","year":"2001","journal-title":"Nature Cell Biol."},{"key":"10.1006\/excr.2001.5449_RF13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.cb.03.110187.002303","article-title":"Polypeptide growth factors: Roles in normal and abnormal cell growth","volume":"3","author":"Deuel","year":"1988","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1006\/excr.2001.5449_RF14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","article-title":"Mechanism of action and in vivo role of platelet-derived growth factor","volume":"79","author":"Heldin","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1006\/excr.2001.5449_RF15","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1128\/MCB.14.10.6715","article-title":"Tyr-716 in the platelet-derived growth factor b-receptor kinase insert is involved in GRB2 binding and ras activation","volume":"14","author":"Arvidsson","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2001.5449_RF16","doi-asserted-by":"crossref","first-page":"30942","DOI":"10.1074\/jbc.271.48.30942","article-title":"Grb7 is a downstream signaling component of platelet-derived growth factor a and b receptors","volume":"271","author":"Yokote","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5449_RF17","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1128\/MCB.12.12.5824","article-title":"The SH2 and SH3 domain-containing Nck protein is oncogenic and a common target for phosphorylation by different surface receptors","volume":"12","author":"Li","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2001.5449_RF18","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/j.1460-2075.1992.tb05182.x","article-title":"Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo","volume":"11","author":"Kashishian","year":"1992","journal-title":"EMBO J."},{"key":"10.1006\/excr.2001.5449_RF19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1128\/MCB.11.2.1125","article-title":"A phosphotidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine","volume":"11","author":"Escobedo","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2001.5449_RF20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0092-8674(91)90409-R","article-title":"cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF \u03b2-receptor","volume":"65","author":"Escobedo","year":"1991","journal-title":"Cell"},{"key":"10.1006\/excr.2001.5449_RF21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0092-8674(90)90013-5","article-title":"Association between the PDGF receptor and members of the src family of tyrosine kinases","volume":"62","author":"Kypta","year":"1990","journal-title":"Cell"},{"key":"10.1006\/excr.2001.5449_RF22","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/j.1460-2075.1993.tb05879.x","article-title":"Identification of two juxtamembrane autophosphorylation sites in the PDGF b-receptor; involvement in the interaction with Src family tyrosine kinases","volume":"12","author":"Mori","year":"1993","journal-title":"EMBO J."},{"key":"10.1006\/excr.2001.5449_RF23","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1073\/pnas.90.15.6939","article-title":"The 64-kDa protein that associates with the platelet-derived growth factor receptor b subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp","volume":"90","author":"Kazlauskas","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2001.5449_RF24","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1002\/j.1460-2075.1992.tb05484.x","article-title":"Identification of two C-terminal autophosphorylation sites in the PDGF b-receptor: Involvement in the interaction with phospholipase C-g","volume":"11","author":"Ronnstrand","year":"1992","journal-title":"EMBO J."},{"key":"10.1006\/excr.2001.5449_RF25","doi-asserted-by":"crossref","first-page":"9011","DOI":"10.1074\/jbc.272.14.9011","article-title":"Platelet-derived growth factor-dependent cellular transformation requires either phospholipase Cgamma or phosphatidylinositol 3 kinase","volume":"272","author":"DeMali","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5449_RF26","first-page":"731","article-title":"Expression of an ATP Binding Mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells","volume":"13","author":"Li","year":"1996","journal-title":"Oncogene"},{"key":"10.1006\/excr.2001.5449_RF27","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1091\/mbc.3.10.1131","article-title":"Induction of NF-kappa B-like activity by platelet-derived growth factor in mouse fibroblasts","volume":"3","author":"Olashaw","year":"1992","journal-title":"Mol. Biol. Cell"},{"key":"10.1006\/excr.2001.5449_RF28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/43474","article-title":"NF-\u03baB is a target of AKT in anti-apoptotic PDGF signaling","volume":"401","author":"Romashkova","year":"1999","journal-title":"Nature"},{"key":"10.1006\/excr.2001.5449_RF29","doi-asserted-by":"crossref","first-page":"24113","DOI":"10.1074\/jbc.272.39.24113","article-title":"Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation","volume":"272","author":"Finco","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5449_RF30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/sj.onc.1204257","article-title":"Her-2\/neu overexpression induces NF-kappaB via a PI3-kinase\/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN","volume":"20","author":"Pianetti","year":"2001","journal-title":"Oncogene"},{"key":"10.1006\/excr.2001.5449_RF31","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.12.7.968","article-title":"A requirement for NF-\u03baB activation in Bcr-Abl-mediated transformation","volume":"12","author":"Reuther","year":"1998","journal-title":"Genes Dev."},{"key":"10.1006\/excr.2001.5449_RF32","first-page":"63","article-title":"The inducible trnascription activator NF-\u03baB: regulation by distinct protein subunits","volume":"1072","author":"Baeuerle","year":"1991","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1006\/excr.2001.5449_RF33","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1091\/mbc.3.12.1339","article-title":"I kappa B\/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding","volume":"3","author":"Ganchi","year":"1992","journal-title":"Mol. Biol. Cell"},{"key":"10.1006\/excr.2001.5449_RF34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/1074-7613(95)90112-4","article-title":"Mechanistic aspects of NF-\u03baB regulation: The emerging role of phosphorylation and proteolysis","volume":"3","author":"Finco","year":"1995","journal-title":"Immunity"},{"key":"10.1006\/excr.2001.5449_RF35","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1002\/j.1460-2075.1993.tb06157.x","article-title":"In vivo control of NF-\u03baB activation by I\u03baBa","volume":"12","author":"Rice","year":"1993","journal-title":"EMBO J."},{"key":"10.1006\/excr.2001.5449_RF36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-5793(96)01409-3","article-title":"Nuclear factor-kappaB activation in human monocytes stimulated with lipopolysaccharide is inhibited by fibroblast conditioned medium and exogenous PGE2","volume":"400","author":"Conte","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1006\/excr.2001.5449_RF37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells [published erratum appears in Cell 1998 Jul 24;94(2): following 271]","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell"},{"key":"10.1006\/excr.2001.5449_RF38","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kB by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1006\/excr.2001.5449_RF39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/ki.1996.288","article-title":"Regulation of platelet-derived growth factor isoform-mediated expression of prostaglandin G\/H synthase in mesangial cells","volume":"50","author":"Goppelt-Struebe","year":"1996","journal-title":"Kidney Int."},{"key":"10.1006\/excr.2001.5449_RF40","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1093\/nar\/13.14.5007","article-title":"Nucleotide sequence of transforming human c-sis cDNA clones with homology to platelet-derived growth factor","volume":"13","author":"Ratner","year":"1985","journal-title":"Nucleic Acids Res."},{"key":"10.1006\/excr.2001.5449_RF41","first-page":"2391","article-title":"Failure of the splicing variant p65 delta of the NF-kappa B subunit p65 to transform fibroblasts","volume":"9","author":"Grimm","year":"1994","journal-title":"Oncogene"},{"key":"10.1006\/excr.2001.5449_RF42","first-page":"1431","article-title":"An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein","volume":"10","author":"Riese","year":"1995","journal-title":"Oncogene"},{"key":"10.1006\/excr.2001.5449_RF43","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1006\/excr.2001.5449_RF44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2144\/01303bm07","article-title":"Use of fluorescently labeled DNA and a scanner for electrophoretic mobility shift assays","volume":"30","author":"Murphy","year":"2001","journal-title":"Biotechniques"},{"key":"10.1006\/excr.2001.5449_RF45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/mpat.1998.0213","article-title":"Selective inhibition of TNF-alpha induced cell adhesion molecule gene expression by tanapox virus","volume":"25","author":"Paulose","year":"1998","journal-title":"Microb. Pathog."},{"key":"10.1006\/excr.2001.5449_RF46","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q","article-title":"Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma","volume":"82","author":"Rosenberg","year":"1998","journal-title":"Cancer"},{"key":"10.1006\/excr.2001.5449_RF47","first-page":"4629","article-title":"Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases","volume":"60","author":"Attiga","year":"2000","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2001.5449_RF48","doi-asserted-by":"crossref","first-page":"19134","DOI":"10.1074\/jbc.271.32.19134","article-title":"Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents","volume":"271","author":"Guo","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5449_RF49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jcp.1041120204","article-title":"Role of stimulation of arachidonic acid release in the proliferative response of 3T3 mouse fibroblasts to platelet-derived growth factor","volume":"112","author":"Shier","year":"1982","journal-title":"J. Cell. Physiol."},{"key":"10.1006\/excr.2001.5449_RF50","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/j.1460-2075.1991.tb08017.x","article-title":"Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein","volume":"10","author":"Petti","year":"1991","journal-title":"EMBO J."},{"key":"10.1006\/excr.2001.5449_RF51","first-page":"689","article-title":"Bovine papillomavirus oncoprotein E5 induces the NF kappa B activation through superoxide radicals","volume":"40","author":"Kilk","year":"1996","journal-title":"Biochem Mol. Biol. Int."},{"key":"10.1006\/excr.2001.5449_RF52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/abbi.1995.1130","article-title":"Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid","volume":"317","author":"Bhattacharyya","year":"1995","journal-title":"Arch. Biochem Biophys."},{"key":"10.1006\/excr.2001.5449_RF53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1124\/mol.51.1.52","article-title":"Altered sensitivity of aspirin-acetylated prostaglandin G\/H synthase-2 to inhibition by nonsteroidal anti-inflammatory drugs","volume":"51","author":"Mancini","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1006\/excr.2001.5449_RF54","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1021\/bi00289a010","article-title":"Isolation and covalent structure of the aspirin-modified, active-site region of prostaglandin synthetase","volume":"22","author":"Roth","year":"1983","journal-title":"Biochemistry"},{"key":"10.1006\/excr.2001.5449_RF55","first-page":"366","article-title":"Inhibition of DNA synthesis by aspirin in Swiss 3T3 fibroblasts","volume":"280","author":"Castano","year":"1997","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1006\/excr.2001.5449_RF56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammtory agents aspirin and salicylate inhibit the activity of IkBkinase-b","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"10.1006\/excr.2001.5449_RF57","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1073\/pnas.89.5.1529","article-title":"Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation","volume":"89","author":"Perkins","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2001.5449_RF58","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1128\/MCB.19.8.5785","article-title":"NF-\u03baB controls growth and differentiation through transcriptional regualtion of cyclin D1","volume":"19","author":"Guttridge","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2001.5449_RF59","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1128\/MCB.19.4.2690","article-title":"NF-\u03baB function in growth control: regulation of cyclin D1 expression and G0\/G1-to-S-phase transition","volume":"19","author":"Hinz","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2001.5449_RF60","doi-asserted-by":"crossref","first-page":"32739","DOI":"10.1074\/jbc.272.52.32739","article-title":"Inhibition of nuclear factor-kappaB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis","volume":"272","author":"Shao","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5449_RF61","first-page":"7413","article-title":"E1A inhibition of radiation-induced NF-kappaB activity through suppression of IKK activity and IkappaB degradation, independent of Akt activation","volume":"61","author":"Shao","year":"2001","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2001.5449_RF62","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1126\/science.276.5320.1848","article-title":"Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase","volume":"276","author":"Chang","year":"1997","journal-title":"Science"},{"key":"10.1006\/excr.2001.5449_RF63","doi-asserted-by":"crossref","first-page":"26325","DOI":"10.1074\/jbc.272.42.26325","article-title":"Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice","volume":"272","author":"Huang","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5449_RF64","first-page":"3569","article-title":"Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response","volume":"57","author":"Li","year":"1997","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2001.5449_RF65","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0378-1119(88)90151-5","article-title":"Analysis of a transformed cell line using antisense c-fos RNA","volume":"72","author":"Mercola","year":"1988","journal-title":"Gene"},{"key":"10.1006\/excr.2001.5449_RF66","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1038\/sj.onc.1201798","article-title":"Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes","volume":"16","author":"Li","year":"1998","journal-title":"Oncogene"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482701954497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482701954497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T12:36:59Z","timestamp":1622032619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482701954497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S0014482701954497"],"URL":"https:\/\/doi.org\/10.1006\/excr.2001.5449","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}